Kidney Disease after Heart and Lung Transplantation

Area of Science:

• Nephrology
• Transplantation Medicine
• Immunology

Background:

• Chronic kidney disease (CKD) is a significant complication following lung and heart transplantation.
• CKD in transplant recipients is associated with increased morbidity and mortality.
• The incidence of CKD is rising, partly due to the transplantation of older recipients with comorbidities.

Purpose of the Study:

• To review risk factors associated with CKD after lung and heart transplantation.
• To discuss potential interventions to mitigate CKD in this patient population.
• To critically evaluate the role of pretransplant renal function and calcineurin inhibitor nephrotoxicity.

Main Methods:

• Literature review of studies on CKD in lung and heart transplant recipients.
• Analysis of pre-, peri-, and post-transplant factors contributing to CKD.
• Discussion of existing and potential therapeutic strategies.

Main Results:

• Multiple factors pre-, during, and post-transplant contribute to CKD.
• Pretransplant renal function is a key determinant of post-transplant kidney health.
• The role of calcineurin inhibitors in chronic nephrotoxicity may be overestimated.

Conclusions:

• CKD is a serious, multifactorial complication in lung and heart transplant recipients.
• Further research, beyond observational studies, is needed to understand CKD pathophysiology.
• Developing targeted interventions is essential to improve long-term outcomes for transplant patients.